These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2571386)

  • 61. Immunoglobulin A--alpha-1-antitrypsin complex in rheumatic diseases.
    Lacki JK; Klama K; Mackiewicz SH
    Mater Med Pol; 1996; 28(4):138-40. PubMed ID: 9308336
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Raised titres of anti-klebsiella IgA in ankylosing spondylitis, rheumatoid arthritis, and inflammatory bowel disease.
    Cooper R; Fraser SM; Sturrock RD; Gemmell CG
    Br Med J (Clin Res Ed); 1988 May; 296(6634):1432-4. PubMed ID: 3132277
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tinnitus and bilateral sensorineural hearing loss: ankylosing spondylitis or a side-effect of sulphasalazine treatment?
    Savastano M; Marioni G; Bernini G; Punzi L
    Acta Otolaryngol; 2005 Jun; 125(6):671-3. PubMed ID: 16076720
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial.
    van der Heijde D; Baraliakos X; Gensler LS; Maksymowych WP; Tseluyko V; Nadashkevich O; Abi-Saab W; Tasset C; Meuleners L; Besuyen R; Hendrikx T; Mozaffarian N; Liu K; Greer JM; Deodhar A; Landewé R
    Lancet; 2018 Dec; 392(10162):2378-2387. PubMed ID: 30360970
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Limited effect of sulphasalazine treatment in reactive arthritis. A randomised double blind placebo controlled trial.
    Egsmose C; Hansen TM; Andersen LS; Beier JM; Christensen L; Ejstrup L; Peters ND; van der Heijde DM
    Ann Rheum Dis; 1997 Jan; 56(1):32-6. PubMed ID: 9059138
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis: comment on the article by Clegg et al.
    Helliwell PS
    Arthritis Rheum; 1997 Oct; 40(10):1911-2. PubMed ID: 9336437
    [No Abstract]   [Full Text] [Related]  

  • 67. Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs cooperative study.
    Clegg DO; Reda DJ; Abdellatif M
    Arthritis Rheum; 1999 Nov; 42(11):2325-9. PubMed ID: 10555027
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Analysis of uveitis rates across all etanercept ankylosing spondylitis clinical trials.
    Sieper J; Koenig A; Baumgartner S; Wishneski C; Foehl J; Vlahos B; Freundlich B
    Ann Rheum Dis; 2010 Jan; 69(1):226-9. PubMed ID: 19465402
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A double-blind, placebo-controlled trial of low dose infliximab in ankylosing spondylitis.
    Inman RD; Maksymowych WP;
    J Rheumatol; 2010 Jun; 37(6):1203-10. PubMed ID: 20231198
    [TBL] [Abstract][Full Text] [Related]  

  • 70. IgA containing immune complexes and hematuria in ankylosing spondylitis. A prospective longitudinal study.
    Peeters AJ; van den Wall Bake AW; van Albada-Kuipers GA; Westedt ML; Brand R; Breedveld FC; van Es LA; Cats A
    J Rheumatol; 1988 Nov; 15(11):1662-7. PubMed ID: 3236300
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The binding of alpha-1 antitrypsin to human IgA.
    Tomasi TB; Hauptman SP
    J Immunol; 1974 Jun; 112(6):2274-7. PubMed ID: 4207732
    [No Abstract]   [Full Text] [Related]  

  • 72. Serum IgA, acute phase proteins, and glycosylation of alpha 1-acid glycoprotein in ankylosing spondylitis.
    Mackiewicz A; Khan MA; Reynolds TL; van der Linden S; Kushner I
    Ann Rheum Dis; 1989 Feb; 48(2):99-103. PubMed ID: 2467628
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study.
    Dougados M; vam der Linden S; Leirisalo-Repo M; Huitfeldt B; Juhlin R; Veys E; Zeidler H; Kvien TK; Olivieri I; Dijkmans B
    Arthritis Rheum; 1995 May; 38(5):618-27. PubMed ID: 7748217
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Treatment of the seronegative spondyloarthropathies with sulfasalazine.
    Zwillich SH; Comer SS; Lee E; Erdman WA; Lipsky PE
    J Rheumatol Suppl; 1988 Sep; 16():33-9. PubMed ID: 2903925
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sulfasalazine and ankylosing spondylitis.
    Amor B; Kahan A; Dougados M; Delrieu F
    Ann Intern Med; 1984 Dec; 101(6):878. PubMed ID: 6149718
    [No Abstract]   [Full Text] [Related]  

  • 76. Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis.
    Brandt J; Khariouzov A; Listing J; Haibel H; Sörensen H; Grassnickel L; Rudwaleit M; Sieper J; Braun J
    Arthritis Rheum; 2003 Jun; 48(6):1667-75. PubMed ID: 12794835
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Systemic and mucosal antibodies to Klebsiella in patients with ankylosing spondylitis and Crohn's disease.
    O'Mahony S; Anderson N; Nuki G; Ferguson A
    Ann Rheum Dis; 1992 Dec; 51(12):1296-300. PubMed ID: 1485810
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Predictors of Clinical Remission under Anti-tumor Necrosis Factor Treatment in Patients with Ankylosing Spondylitis: Pooled Analysis from Large Randomized Clinical Trials.
    Baraliakos X; Koenig AS; Jones H; Szumski A; Collier D; Bananis E
    J Rheumatol; 2015 Aug; 42(8):1418-26. PubMed ID: 26077401
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical research for curing ankylosing spondylitis through combining etanercept, thalidomide and sulfasalazine.
    Xiao P; Pang C; Zhu X; Wu X
    Pak J Pharm Sci; 2015 Jan; 28(1 Suppl):359-62. PubMed ID: 25631513
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cutaneous vasculitis and IgA glomerulonephritis in ankylosing spondylitis.
    Beauvais C; Kaplan G; Mougenot B; Michel C; Marinho E
    Ann Rheum Dis; 1993 Jan; 52(1):61-2. PubMed ID: 8427517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.